LEXICON
No.151 March 4, 2016

Market expansion re-pricing
市場拡大再算定

The basic principle of biennial drug price revisions is to update NHI reimbursement drug prices based on actual market prices, which are investigated through market price surveys/drug price surveys (薬価調査; yakka chosa ) prior to each revision. To curtail medical...

To read the full story

LEXICON

Takeda Pharmaceutical CEO Christophe Weber highlighted the importance of gaining a strong foothold in the world’s largest pharma market at…

By Reiji Anasako

While generic drugs post solid growth in volume-based shares in Japan, their makers are pondering ways to retool their business…

By Yoshinori Sagehashi

Daiichi Sankyo and GlaxoSmithKline recently announced that they have agreed to dissolve their joint venture company, Japan Vaccine. The failure of this model of joint venture between a major Japanese and foreign drug maker in just six years is disappointing.Over…

By Gregory Ng

To many people, Japan has always been one of the world’s most advanced economies and a market of rich opportunities with one of the top healthcare systems worldwide.Add a rapidly changing demographic, a declining workforce, and the constant challenges of…